investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Harnessing beneficial off-target effects of kinase inhibitors in lung cancer

Uwe Rix

4 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Uwe Rix

Moffitt Cancer Center

Tampa, United States

University of South Florida

Tampa, United States

Thomas Metz

Oncotest GmbH

Freiburg, Germany

Related projects

Martin Mcmahon

Studying the Initiation, Progression and Therapy of Lung Cancer in Mouse Models

Trachea, bronchus and lung

Pathology

Patricia Steeg

Molecular Biology of the Metastatic Phenotype

Trachea, bronchus and lung

Pathology

Brid Ryan

Examining the Inverse Relationship Between Parkinson's Disease and Lung Cancer

Trachea, bronchus and lung

Pathology

Robert Gillies

Radiomics of Non-Small Cell Lung Cancer (NSCLC)

Trachea, bronchus and lung

Pathology

Shioko Kimura

Role of Novel Cytokine-like Molecules Secretoglobin (SCGB) 3A1 and 3A2 in Lung

Trachea, bronchus and lung

Pathology

Marc Nicklaus

In Silico Screening for Cancer Targets

Trachea, bronchus and lung

Pathology

Elsa Flores

Drug Repositioning for Pharmacological Manipulation of p53 Family Members in p53 Mutant and Deficient Lung Tumors

Trachea, bronchus and lung

Pathology

Jennifer Brady

Mechanisms governing tumor differentiation and metastasis

Trachea, bronchus and lung

Pathology

Joseph R Testa

RIP1/3 Kinases as New Targets in Malignant Mesothelioma

Trachea, bronchus and lung

Pathology